| Cara Mayberry, | |
|
1824 Commons Cir Ste B, Yukon, OK 73099-9538 | |
| (405) 467-6782 | |
| Not Available |
| Full Name | Cara Mayberry |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1824 Commons Cir Ste B, Yukon, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043949076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cara Mayberry, 1824 Commons Cir Ste B, Yukon, OK 73099-9538 Ph: () - | Cara Mayberry, 1824 Commons Cir Ste B, Yukon, OK 73099-9538 Ph: (405) 467-6782 |
News Archive
Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.
Wake Forest Baptist Medical Center has received a $3.8 million, five-year grant from the National Institute for Neurological Disorders and Stroke, part of the National Institutes of Health, to continue studying the effects of head impacts in youth league football.
Biocept, Inc., an emerging leader in rare cell capture, announced today that the U.S. Patent and Trademark Office has issued a patent for Biocept's cell separation technology using a microfluidic device. U.S. patent #7,695,956 entitled "Device for Cell Separation and Analysis and Method of Using" protects Biocept's microflow device to isolate cells from a bodily fluid using a flow path where straight-line flow is interrupted by transverse posts arranged in a random pattern.
Less than 50% of patients with esophageal carcinoma are suitable for surgery at the time of diagnosis. Most of these patients present with locally advanced or metastatic disease and/or significant comorbidities. In such circumstances, the only therapeutic option is palliative care to treat dysphagia and prevent respiratory complications secondary to aspiration. Self-expanding metal stents have been proven effective for palliation of dysphagia in patients with esophageal carcinoma, tracheo-esophageal fistulas or anastomotic leaks.
› Verified 9 days ago
Haley Elizabeth Ruhlmann, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1824 Commons Cir Ste B, Yukon, OK 73099 Phone: 405-324-0961 | |
Mrs. Judy Kay Dicus, MED CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11200 Nw 109th St, Yukon, OK 73099 Phone: 405-255-9428 | |
Speech For Kids Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 656 Kingston Pl, Yukon, OK 73099 Phone: 405-777-9160 Fax: 405-592-6313 | |
Mrs. Kelly Sparks, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4928 Cinderwood Dr, Yukon, OK 73099 Phone: 405-350-2654 | |
Leigh Kashea Aneshansley, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 S Mustang Rd, Apt. 2712, Yukon, OK 73099 Phone: 580-309-0394 | |
Mrs. Melissa Kay Longhurst, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4301 N Sara Rd Ste 120, Yukon, OK 73099 Phone: 405-982-2086 Fax: 405-900-4062 |